EMA Wants Pharmaceutical Companies To Limit The Presence Of Nitrosamines In Human Medicines As Far As Possible
EMA’s human medicines committee (CHMP) has issued an opinion requiring companies to take measures to limit the presence of nitrosamines in human medicines as far as possible and to ensure…
Share